Metformin and MOTS-c Interaction
Metformin and MOTS-c have an interaction requiring monitoring for interaction with 90% confidence. Both activate AMPK; monitor for additive hypoglycemic effects. Both compounds affect the pancreas, so monitoring these systems is recommended.
Compound Profiles
Metformin
Biguanide | AMPK Activator & Longevity Research
Metformin exerts its primary effects through activation of AMP-activated protein kinase (AMPK), the cell's master energy sensor. AMPK activation triggers a cascade of downstream metabolic improvements: enhanced glucose uptake in skeletal muscle, suppression of hepatic gluconeogenesis, improved mitochondrial function, and increased fatty acid oxidation.
View full profileMOTS-c
Mitochondrial-Derived Peptide | Metabolic Regulator
Inhibits the folate cycle leading to AMPK activation. Under metabolic stress, translocates to nucleus to bind stress-response transcription factors, regulating genes involved in metabolism, insulin sensitivity, and cellular adaptation.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Metformin with MOTS-c?
Yes, but with caution. Both activate AMPK; monitor for additive hypoglycemic effects. Regular monitoring is advised.
Is Metformin and MOTS-c safe together?
Based on documented research, this combination is considered monitor. However, shared safety flags include: insulin sensitizing. Monitor accordingly.
What are the interactions between Metformin and MOTS-c?
Both activate AMPK; monitor for additive hypoglycemic effects. This assessment has 90% confidence and is based on documented research data.
How should I time Metformin and MOTS-c?
Metformin has a half-life of ~5 hours and MOTS-c has a half-life of ~30 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.